Select your location.
*e-commerce not available for this region.
Get exclusive pricing on all online purchases.
Login to your Revvity.com account for your account's pricing, easy re-ordering from favorites & order history, priority order processing, and dynamic order tracking.
Initiate a new order or access test status and results for clinical genomics or newborn screening services.
The CHOSOURCE™ Glutamine Synthetase (GS) knockout (KO) cell line is a well-established, cGMP-manufactured CHO-K1-derived suspension cell line, specifically engineered by knocking-out the glutamine synthetase gene to provide a robust industry standard selection system. The GS KO selection system facilitates the selection of high expressing clones during cell line development, accelerating cell line development timelines with high efficiency cell line screening.
Since its introduction in 2016, over 100 licensees have adopted this cell line globally and it has supported over 100 clinical trial authorizations (IND, CTA, CTN). To make regulatory submissions even easier, we have made a drug master file (DMF) submission.
Industry standard
Track record and regulatory compliance
Truly adaptable platform
Dedicated team
The CHOSOURCE™ Platform is available for research, clinical, diagnostic, and commercialization applications, including services, under specific licenses from Revvity.